Drax rivals Foresight bid for HEIT
Drax Group’s bid, which is being recommended by the HEIT board, comes at a 5% premium to the Foresight offer
Drax Group’s bid, which is being recommended by the HEIT board, comes at a 5% premium to the Foresight offer
George Latham, managing partner at WHEB, explains why cultural alignment was crucial
Deal will add almost £800m to Foresight’s AUM
With buyers placing increasing emphasis ESG practices, sellers must proactively address these areas to remain competitive
Whitefriars’ Ketan Patel discusses what investors need to consider when investing in the pharmaceutical sector
Overall deal outlook optimistic
New firm headed by Emma Bickerstaffe
Acquired Danish bond firm Absalon
AERI board exploring a range of initiatives to address ‘issues facing the sector’
North Carolina-based Earth Equity Advisors is a certified B Corporation
‘We try to invest in the next economy rather than the last economy’
Deal will create tools using ACA’s tech and advice offering and Ethos ESG’s analytics